Noninvasive Digital Detection of Fetal DNA in Plasma of 4-Week-Pregnant Women following In Vitro Fertilization and Embryo Transfer

• Published in: PloS one Vol. 10; no. 5; p. e0126501
• Main Authors: Karakas, Bedri, Qubbaj, Wafa, Al-Hassan, Saad, Coskun, Serdar
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 13-05-2015; Public Library of Science (PLoS)
• Subjects: Beads; Blood; Blood circulation; Cancer; Chromosomes; Chromosomes, Human, Y - genetics; Deoxyribonucleic acid; DNA; DNA - blood; Embryo Transfer; Embryos; Emulsions; Feasibility studies; Female; Fertilization; Fertilization in Vitro; Fetus - physiology; Fetuses; Gene sequencing; Genetic aspects; Genetic testing; Girls; Humans; In vitro fertilization; Innovations; Laboratories; Male; Medical research; Mutation; Oncology; Placenta; Plasma; Polymerase Chain Reaction; Pregnancy; Prenatal diagnosis; Properties; Sensitivity and Specificity; Sex Determination Analysis - methods; Treatment Outcome; Womens health; Y Chromosomes
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0126501

The discovery of cell-free fetal DNA (cfDNA) circulating in the maternal blood has provided new opportunities for noninvasive prenatal diagnosis (NIPD). However, the extremely low levels of cfDNA within a high background of the maternal DNA in maternal circulation necessitate highly sensitive molecular techniques for its reliable use in NIPD. In this proof of principle study, we evaluated the earliest possible detection of cfDNA in the maternal plasma by a bead-based emulsion PCR technology known as BEAMing (beads, emulsion, amplification, magnetics). Blood samples were collected from in vitro fertilization (IVF) patients at 2 to 6 weeks following embryo transfer (i.e., 4 to 8 week pregnancies) and plasma DNA was extracted. The genomic regions of both X and Y chromosome-specific sequences (AMELX and AMELY) were concurrently amplified in two sequential PCRs; first by conventional PCR then by BEAMing. The positive beads either for AMELX or AMELY gene sequences were counted by a flow cytometer. Our results showed that the pregnancies yielding boys had significantly higher plasma AMELY gene fractions (0.512 ± 0.221) than the ones yielding girls (0.028 ± 0.003) or non-pregnant women (0.020 ± 0.005, P= 0.0059). Here, we clearly demonstrated that the BEAMing technique is capable of reliably detecting cfDNA in the blood circulation of 4-week-pregnant women, which is only two weeks after the embryo transfer. BEAMing technique can also be used to early detect fetal DNA alterations in other pregnancy-associated disorders.